No CrossRef data available.
Article contents
A Controlled Trial of Cosaldon in Arteriosclerotic Dementia
Published online by Cambridge University Press: 29 January 2018
Extract
Cosaldon has been fairly widely used on the Continent in the treatment of dementia and toxic confusional states. Meyer (1957), Leube (1959), Sperling (1960), Schmidt (1960), and Donati (1960) consider the drug to be of particular value in the treatment of arteriosclerotic dementia, and stress that the earlier the treatment is commenced the more favourable is the response.
- Type
- Research Article
- Information
- Copyright
- Copyright © Royal College of Psychiatrists, 1964
References
Bjurwill, B. (1963). “The effect of Cosaldon in elderly patients with cerebral sclerosis on the ability to orientate, memorize and think”, Swedish Med. J. Dnr., 3, 682.Google Scholar
Florey, H. W. (1925). “Microscopical observations on the circulation of the blood in the cerebral cortex”, Brain, 48, 43–64.Google Scholar
Leube, H. (1959). “Contribution to the therapy of cerebral sclerosis”, Arzt. Praxis, 12, 388–390.Google Scholar
Raven, J. C. (1947). “Guide to using Progressive Matrices”, Sets A, AB, B.
London: Lewis.Google Scholar
eLetters
No eLetters have been published for this article.